Inge Thulin Biography and Net Worth

Director of Merck & Co., Inc.

Mr. Thulin has extensive management, operational, technology and international business expertise, as demonstrated by a track record of success leading 3M Company. Mr. Thulin possesses broad industry experience drawn from 3M's diverse businesses, commitment to research and strong life sciences division. He also brings valuable insight into driving innovation, based on his experience with new product development and manufacturing. In addition, his previous directorships at other public companies provide him with deep experience on governance issues facing large public companies.

What is Inge G. Thulin's net worth?: The estimated net worth of Inge G. Thulin is at least $295.79 thousand as of February 6th, 2025. Mr. Thulin owns 2,933 shares of Merck & Co., Inc. stock worth more than $295,793 as of December 5th. This net worth approximation does not reflect any other assets that Mr. Thulin may own. Learn More about Inge G. Thulin's net worth.
How do I contact Inge G. Thulin?: The corporate mailing address for Mr. Thulin and other Merck & Co., Inc. executives is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. Merck & Co., Inc. can also be reached via phone at (908) 740-4000 and via email at [email protected]. Learn More on Inge G. Thulin's contact information.
Has Inge G. Thulin been buying or selling shares of Merck & Co., Inc.?: Inge G. Thulin has not been actively trading shares of Merck & Co., Inc. within the last three months. Most recently, on Thursday, February 6th, Inge G. Thulin bought 2,833 shares of Merck & Co., Inc. stock. The stock was acquired at an average cost of $88.25 per share, with a total value of $250,012.25. Following the completion of the transaction, the director now directly owns 2,933 shares of the company's stock, valued at $258,837.25. Learn More on Inge G. Thulin's trading history.
Who are Merck & Co., Inc.'s active insiders?: Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Robert Davis (CFO), Richard Deluca (EVP), Cristal Downing (Insider), Kenneth Frazier (Insider), Julie Gerberding (EVP), Clark Golestani (EVP), Michael Holston (EVP), Rita Karachun (VP), Caroline Litchfield (CFO), Steven Mizell (EVP), Johannes Oosthuizen (Insider), Joseph Romanelli (Insider), Inge Thulin (Director), Ashley Watson (SVP), Wendell Weeks (Director), and David Williams (Executive vice president, chief information & digital officer). Learn More on Merck & Co., Inc.'s active insiders.
Are insiders buying or selling shares of Merck & Co., Inc.?: During the last year, Merck & Co., Inc. insiders bought shares 1 times. They purchased a total of 2,833 shares worth more than $250,012.25. During the last year, insiders at the sold shares 3 times. They sold a total of 15,237 shares worth more than $1,282,329.74. The most recent insider tranaction occured on November, 3rd when EVP David Michael Williams sold 8,614 shares worth more than $720,044.26. Insiders at Merck & Co., Inc. own 0.1% of the company. Learn More about insider trades at Merck & Co., Inc..
Information on this page was last updated on 11/3/2025.

Inge G. Thulin Insider Trading History at Merck & Co., Inc.

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/6/2025	Buy	2,833	$88.25	$250,012.25	2,933

Inge G. Thulin Buying and Selling Activity at Merck & Co., Inc.

Merck & Co., Inc. Company Overview

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Today's Range

Now: $100.85

$100.54

$102.60

50 Day Range

MA: $90.43

$78.46

$105.71

2 Week Range

Now: $100.85

$73.31

$105.84

Volume

12,757,948 shs

Average Volume

14,661,325 shs

Market Capitalization

$250.31 billion

P/E Ratio

13.32

Dividend Yield

3.17%

Beta

0.29